BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6954069)

  • 1. Deferoxamine mesylate enhancement of 67Ga tumor-to-blood ratios and tumor imaging.
    Koizumi K; Tonami N; Hisada K
    Eur J Nucl Med; 1982; 7(5):229-33. PubMed ID: 6954069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and excretion of 67Ga-citrate in malignant tumors and normal cells.
    Muranaka A; Ito Y; Hashimoto M; Namba M; Nishitani K; Otsuka N; Nagai K; Narabayashi I; Kaji T
    Eur J Nucl Med; 1980; 5(1):31-7. PubMed ID: 7379803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative tumour enhancement of 67Ga uptake by desferrioxamine.
    Hammersley PA
    Eur J Nucl Med; 1984; 9(10):461-71. PubMed ID: 6595115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of deferoxamine mesylate on gallium-67 distribution in normal and abscess-bearing animals: concise communication.
    Oster ZH; Som P; Sacker DF; Atkins HL
    J Nucl Med; 1980 May; 21(5):421-5. PubMed ID: 7373412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Ga-67 labeled DFO-DAS-fibrinogen conjugate as a thrombus imaging agent.
    Yamaoka S
    Radiat Med; 1987; 5(5):151-3. PubMed ID: 3438481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of labeling efficiency, biological activity and biodistribution among 125I-, 67Ga-DTPA-and 67Ga-DFO-lectins.
    Kojima S; Jay M
    Eur J Nucl Med; 1987; 13(7):366-70. PubMed ID: 3428286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive imaging of venous thrombi and thromboemboli with Ga-67 DFO-DAS-fibrinogen.
    Yamamoto K; Senda M; Fujita T; Kumada K; Fukui K; Yonekura Y; Yokoyama A; Torizuka K
    Eur J Nucl Med; 1988; 14(2):60-4. PubMed ID: 3391213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different actions of deferoxamine and iron on Ga-67 abscess detection in rats.
    Oberhaensli RD; Mueller RM; Fridrich R
    J Nucl Med; 1984 Jun; 25(6):668-72. PubMed ID: 6587029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
    Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
    Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of radioisotopes with tumor affinity. I. Uptake and excretion of 67Ga-citrate in malignant tumors and normal cells.
    Muranaka A
    Acta Med Okayama; 1978 Dec; 32(6):407-17. PubMed ID: 154826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential uptake of gallium-67-labeled liposomes between tumors and inflammatory lesions in rats.
    Ogihara I; Kojima S; Jay M
    J Nucl Med; 1986 Aug; 27(8):1300-7. PubMed ID: 3734903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of Ga-67 DFO-DAS-fibrinogen.
    Yamamoto K; Torizuka K
    Radiat Med; 1987; 5(5):180-2. PubMed ID: 3438488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic enhancement of gallium-67 tumor-to-blood ratios for EMT-6 sarcoma (BALB/c mice).
    Larson SM; Rasey JS; Grunbaum Z; Allen DR
    Radiology; 1979 Jan; 130(1):241-4. PubMed ID: 758657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of iron on 67Ga distribution in tumor-bearing mice--effect of iron administered before 67Ga injection (author's transl)].
    Shimura A; Higashi T; Wakao H
    Radioisotopes; 1981 Jul; 30(7):379-84. PubMed ID: 7323323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors.
    Stolz B; Smith-Jones PM; Albert R; Reist H; Mäcke H; Bruns C
    Horm Metab Res; 1994 Oct; 26(10):453-9. PubMed ID: 7851867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
    Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
    Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelator-induced enhancement of 67Ga tumour imaging: comparison of desferrioxamine with N,N'-ethylene-bis[2-hydroxy-5-carboxyphenylglycine].
    Hunt FC
    Int J Rad Appl Instrum B; 1988; 15(6):651-7. PubMed ID: 3251899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of iron on 67Ga distribution in tumor-bearing mice--effect of iron administered after 67Ga injection (author's transl)].
    Higashi T; Shimura A; Wakao H
    Radioisotopes; 1981 Jul; 30(7):385-90. PubMed ID: 7323324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions.
    Caraco C; Aloj L; Eckelman WC
    Appl Radiat Isot; 1998 Dec; 49(12):1477-9. PubMed ID: 9745687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
    Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
    Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.